Pot stocks are soaring again. Shares of GW Pharmaceuticals (GWPH) surged yesterday after the company announced that the DEA had approved sale of a new cannabis derived drug for treatment of pediatric epilepsy. Earlier Tilray (TLRY) got DEA’s approval to
September 28, 2018